Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Courtney Miller

Foot and Ankle Surgery Highlands Ranch, CO Medical Doctor

NPI 1326300864 CMS profile 458339

1500 Park Central Dr, Highlands Ranch, CO 80129

Open in the dashboard

General payments

$8,347

65 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Courtney Miller of Highlands Ranch, CO is reported in the CMS Open Payments database as having received $8,347 across 65 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 49th percentile of Foot and Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,132 8
2024 General $316 5
2023 General $613 12
2022 General $617 7
2021 General $2,696 18
2019 General $973 15

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Courtney Miller
  • Foot and Ankle Surgery median
  • Middle half of Foot and Ankle Surgery
  • National median

In program year 2025, general payments to Courtney Miller were reported at $3,132. Among 650 Foot and Ankle Surgery profiles paid that year, the median was $1,183 and the middle half received between $267 and $6,309.

Show as a table
Year Courtney Miller Foot and Ankle Surgery median Middle half National median
2019 $973 $1,327 $279–$5,421 $163
2020 $0 $795 $121–$3,473 $114
2021 $2,696 $1,289 $201–$4,963 $132
2022 $617 $1,539 $270–$6,067 $149
2023 $613 $1,117 $257–$5,264 $160
2024 $316 $1,064 $235–$4,944 $164
2025 $3,132 $1,183 $267–$6,309 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Treace Medical Concepts, Inc. $3,280 10 payments
  2. Arthrex, Inc. $2,301 20 payments
  3. Stryker Corporation $943 16 payments
  4. Paragon 28, Inc. $882 4 payments
  5. Gemini Mountain Medical, LLC $218 2 payments
  6. Vilex in Tennessee, Inc. $176 1 payment
  7. Smith+Nephew, Inc. $152 2 payments
  8. DePuy Synthes Sales Inc. $151 4 payments
  9. TriMed, Inc. $135 1 payment
  10. Zimmer Biomet Holdings, Inc. $46 1 payment
  11. Other $63 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,010 54 payments
  2. Consulting Fee $2,800 1 payment
  3. Travel and Lodging $1,337 9 payments
  4. Education $1,200 1 payment
Products named General payments · program years 2019–2025
  1. LAPIPLASTY SYSTEM 1 $2,815 2 payments
  2. TAR $843 3 payments
  3. INFINITY $365 3 payments
  4. LAPIPLASTY SYSTEM $333 5 payments
  5. INBONE $301 4 payments
  6. PROPHECY $294 3 payments
  7. ALPHALOK $176 1 payment
  8. Salto Talaris Total Ankle Prosthesis $152 2 payments
  9. BME NITINOL CONTINUOUS COMPRESSION IMPLANTS $131 2 payments
  10. EVOS MINI $101 1 payment
  11. Other $543 18 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

18

Median for Orthopedic Surgery: 203

Drug cost

$120

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 18 $120

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 72 billing codes

Paid by Medicare

$83,213

Of which drugs: $72

Medicare patients

266

Average age 71

Services billed

643

181 women, 85 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 65%
Depression 24%
Ischemic heart disease 20%
Osteoporosis 20%
Diabetes 19%
Chronic kidney disease 19%
Cancer 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 20 96 $72

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

65 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Foot and Ankle Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record